1
Total deals
$412.0M
Total value
$412.0M
Avg deal
$412.0M
Largest
| # | Acquired | Date | Type | Status | Price | |
|---|---|---|---|---|---|---|
| 1 |
Y-mAbs Therapeutics
YmAbs is a clinical stage biopharmaceutical company that discovers and develops …
|
2025-08-05 | Merge | Complete | $412.0M | Deal → |